New Delhi: Panacea Biotec announced that it has increased the availability of Life Saving Drug Cilamin 250 (D-Penicillamine IP 250 mg) capsules used for treatment of Wilson’s disease, Rheumatoid Arthritis and other conditions. These capsules witnessed short supply in the market during last few months due to non-availability of raw material i.e. D-Penicillamine, in India.
“Panacea Biotec ensures increased availability of life saving drug Cilamin 250 (D—Penicillamine IP 250mg) capsules for the treatment of Wilson’s disease in India,” the company said in a BSE filing. It further said: “Cilamin250 witnessed short supply in the market in the last few months due to non-availability of raw materials D—Penicillamine in India. We have now improved supply of Cilamin 250 capsules, which has been made available in the retail market.”
